Fresenius Medical Care | FME - Cost Of Sales

Stock Price
40.64
Daily Change
0.16 0.40%
Monthly
3.73%
Yearly
-13.20%
Q1 Forecast
36.79

Fresenius Medical Care reported EUR3.64B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.16B 52M Sep/2025
AstraZeneca USD 2.8B 328M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
DaVita Healthcare Partners USD 2.33B 71.22M Sep/2025
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 11.33B 285M Sep/2025
Essilor EUR 5.31B 2.79B Jun/2025
Fresenius EUR 4.19B 62M Sep/2025
Fresenius Medical Care EUR 3.64B 65.63M Sep/2025
Genmab DKK 57M 15M Jun/2025
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GN Store Nord DKK 2.24B 338M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.39B 65M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
RWE EUR 2.48B 938M Sep/2025
Sanofi EUR 4.29B 421M Dec/2025
SAP EUR 2.56B 1.49B Dec/2025
Smith & Nephew USD 870M 17M Dec/2025